高剂量的欧米茄-3脂肪酸优于对偏头痛预防的现有药理选择:一个网络元分析
Ping-Tao Tseng1, Bing-Yan Zeng2, Jiann-Jy Chen3
1Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Psychology, Collage of Medical and Health Science, Taichung, Asia University, Taiwan; Prospect Clinic for Otorhinolaryngology & Neurology, Kaohsiung City, Taiwan; Institute of Precision Medicine, National Sun Yat-sen University, Kaohsiung City, Taiwan.
Advances in nutrition (Bethesda, Md.)
|December 18, 2023
概括
高剂量的乙酸 (EPA) 和多可萨赫萨酸 (DHA) 补充剂显著降低了偏头痛的频率和严重程度. 与其他偏头痛预防方案相比,这种omega-3脂肪酸治疗显示出更高的疗效和可接受性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 偏头痛是一种普遍的神经疾病,影响全球数百万人.
- 目前对偏头痛的预防治疗方法的有效性和安全性概况都不够理想.
- 埃可萨氨酸 (EPA) 和多可萨氨酸 (DHA) 显示出对偏头痛预防的前景.
研究的目的:
- 为了比较不同剂量的EPA/DHA与其他偏头痛预防药物的疗效和可接受性.
- 评估EPA/DHA作为潜在的偏头痛预防的首选治疗方法.
主要方法:
- 进行了随机对照试验 (RCT) 的网络元分析 (NMA).
- 包括40个RCT,6616名参与者被诊断患有偶发性或慢性偏头痛.
- 主要结局是偏头痛频率和可接受性的变化;次要结局包括反应率和不良事件.
主要成果:
- 与安慰剂相比,高剂量的EPA/DHA补充剂导致偏头痛频率 (SMD: -1.36) 和严重程度 (SMD: -2.23) 的最大减少.
- 补充EPA/DHA也显示了所有研究的治疗方法中最有利的接受率.
- 这些发现表明,高剂量EPA/DHA的疗效和耐受性优越.
结论:
- 高剂量的EPA/DHA补充剂是对偏头痛预防的高度有效和可接受的治疗方法.
- 这种omega-3干预可以被认为是偏头痛预防的首选选择.
- 这项研究提供了令人信服的证据,支持EPA/DHA治疗偏头痛.
相关概念视频
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
526
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
526
Antidepressant Drugs: MAOIs and Other Agents
247
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
247
Analgesia and Pain Management
628
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
628


